The Priority Review

Tag

Vera Therapeutics

1 story

  1. Clinical trials

    Results posted for Atacicept study in IgA nephropathy

    Results for this study were first posted on ClinicalTrials.gov on October 1, 2026. The study, a Phase 3, randomized, double-blinded, placebo-controlled trial (NCT04716231), enrolled 428 participants and began on June 29, 2023.